91 related articles for article (PubMed ID: 291484)
1. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484
[No Abstract] [Full Text] [Related]
2. cis-Dichlorodiammineplatinum(II) in childhood cancer.
Freeman AI; Ettinger LJ; Brecher ML
Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.
Dombernowsky P; Sörenson S; Aisner J; Hansen HH
Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119
[No Abstract] [Full Text] [Related]
4. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
[TBL] [Abstract][Full Text] [Related]
5. [Cis-dichlorodiammineplatinum in osteosarcoma. Osteosarcoma Cooperative Study Group report].
Fukuma H; Beppu Y; Chuman H; Yagi T; Yamawaki S; Isu K; Funayama K; Tanuma M; Abe Y; Toriyama S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):811-7. PubMed ID: 2653222
[TBL] [Abstract][Full Text] [Related]
6. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.
Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155
[TBL] [Abstract][Full Text] [Related]
7. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
Rossof AH; Coltman CA; Jones SE; Talley RW
Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
Vietti TJ; Nitschke R; Starling KA; van Eys J
Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Gasparini M; Rouesse J; van Oosterom A; Wagener T; Somers R; Russel JA; Voûte PA; Bramwell V; Thomas D; Sylvester R
Cancer Treat Rep; 1985 Feb; 69(2):211-3. PubMed ID: 3855699
[TBL] [Abstract][Full Text] [Related]
11. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
[TBL] [Abstract][Full Text] [Related]
12. Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.
Hayes FA; Green AA; Senzer N; Pratt CB
Cancer Treat Rep; 1979 Apr; 63(4):547-8. PubMed ID: 445508
[No Abstract] [Full Text] [Related]
13. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
[TBL] [Abstract][Full Text] [Related]
14. [A clinical study of intraarterial infusion therapy with CDDP for primary osteosarcoma].
Eiro I; Kobayashi H; Uchiyama N; Itoh Y; Shinohara S; Itoh H; Morimoto N; Sakoh T
Gan To Kagaku Ryoho; 1990 Jan; 17(1):47-52. PubMed ID: 2297238
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
[No Abstract] [Full Text] [Related]
16. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
Canpolat C; Pearson P; Robertson R; Jaffe N
Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
[TBL] [Abstract][Full Text] [Related]
17. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cis-dichlorodiammineplatinum(II) in cancer of the bilharzial bladder.
Gad-el-Mawla N; Chevlen E; Hamza R; Ziegler JL
Cancer Treat Rep; 1979; 63(9-10):1577-8. PubMed ID: 498157
[No Abstract] [Full Text] [Related]
19. Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Cvitkovic E; Golbey RB
Cancer Treat Rep; 1979; 63(11-12):2107-9. PubMed ID: 575068
[No Abstract] [Full Text] [Related]
20. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
